Health Care/Hospital

Antengene to Present First Preclinical Data on ATG-207 (αCD3-TGF-β Bifunctional Fusion Protein) at EULAR 2026

SHANGHAI and HONG KONG, June 3, 2026 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK) , a leading innovative, commercial-stage global biotech company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class medicines for autoimmune dis...

2026-06-03 12:00 1367

New Research Revealed Effective Surgical Management Techniques for Gynecomastia in Asian Men, Resulting in High Patient Satisfaction

Between 2018 and 2023, Dr Ivan Puah treated over 550 cases, addressing unique challenges in Singapore's multi-ethnic population. His study included diverse case profiles. Results revealing no complications and high satisfaction prove the need to adapt surgical techniques for variations in skin ty...

2026-06-03 10:00 1671

Kelun-Biotech Presents First-in-human Study Data for Its Novel B7-H3 ADC SKB500 at ASCO 2026

CHENGDU, China, June 3, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech" or the "Company", 6990.HK) announced that at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, USA, the first-in-human study results of the novel B7...

2026-06-03 08:00 1437

Reach Surgical Receives CE Mark Approval for SOUND REACH™ Swift

- The leading innovative plug-and-play ultrasonic shears with integrated transducer designed for open surgery SINGAPORE, June 3, 2026 /PRNewswire/ -- Reach Surgical, the surgical solutions division of Genesis MedTech, has received CE Mark approval for SOUND REACHTM Swift, ultrasonic shears desig...

2026-06-03 07:00 1605

HIMSS and SingHealth to Co-Host 2026 HIMSS APAC Health Conference & Exhibition in Singapore to Accelerate Healthcare Transformation

SINGAPORE, June 3, 2026 /PRNewswire/ -- HIMSS, a mission-driven independent society, global thought leader and advisor, will co-host the2026 HIMSS APAC Health Conference & Exhibition

2026-06-03 06:26 1869

Early Data Show Highly Selective FGFR2 Inhibitor 3HP-2827 Active in Advanced CCA; Chinese Academy of Sciences' Zhou Jian Comments on Potential for Patients With FGFR2 Alterations

CHICAGO, June 2, 2026 /PRNewswire/ -- At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting, 3H Pharmaceuticals released new clinical data for its wholly owned candidate, 3HP-2827. The ongoing study focuses on patients with advanced cholangiocarcinoma (CCA) and other solid tumor...

2026-06-02 21:30 3733

Pictor® Reports Strong Commercial Momentum One Year After Launching U.S. Headquarters

The targeted proteomic platform company marks its first anniversary in Carlsbad with four commercial partnerships, seven products, BSL-2 equipped lab, and growing adoption across human and animal health markets globally CARLSBAD, Calif., June 2, 2026 /PRNewswire/ -- As laboratories increasingly ...

2026-06-02 20:48 1693

Everest Medicines Enters into Exclusive Licensing Agreement with Travere Therapeutics for Civorebrutinib a Potential Best-in-Class BTK Inhibitor for Rare Kidney Diseases

* Civorebrutinib is an investigational oral, covalent reversible BTK inhibitor designed to provide differentiated efficacy, safety and convenience in immune-mediated kidney diseases * Civorebrutinib adds pipeline-in-a-product potential across multiple rare kidney diseases, expanding and diver...

2026-06-02 20:27 2048

SK bioscience Secures First UNICEF Procurement Contract Improving Vaccine Access

* First UNICEF procurement contract strengthens SK bioscience's presence in global public procurement markets * Dual-hemisphere supply programs enhance manufacturing efficiency and operational capabilities * Public procurement programs drive both commercial growth and improved vaccine acces...

2026-06-02 20:00 1638

Ping An Launches "Ping An Home" Service Brand

Advancing Proactive Health Management to Meet Chinese Families' Demand for Healthy Longevity HONG KONG and SHANGHAI, June 2, 2026 /PRNewswire/ -- As population aging accelerates and medical standards continue to advance, China is steadily entering an era of longevity. While life expectancy is in...

2026-06-02 14:57 3123

NOVI Health Partners with Novo Nordisk to Expand Access to Structured Weight Care Support in Singapore

The collaboration aims to improve access to lifestyle coaching supported, clinically guided programs for patients exploring medical weight care. SINGAPORE, June 2, 2026 /PRNewswire/ -- NOVI Health today announced a strategic partnership with Novo Nordisk aimed at providing greater access to phys...

2026-06-02 12:52 2748

High-Precision Base-Editing Therapy Demonstrates Durable VOC-Free Efficacy and Favorable Safety in Sickle Cell Disease

CorrectSequence Therapeutics Reports Positive 15-Month Follow-Up Data for CS-206 SHANGHAI, June 2, 2026 /PRNewswire/ -- CorrectSequence Therapeutics Co., Ltd. (Correctseq ), a clinical-stage biotechnology company pioneering transformer Base Editi...

2026-06-02 12:50 2444

NYB.AI Launches Vecura 2.0, Bringing Agentic AI Workflows to Molecular Discovery, with NVIDIA

TAIPEI, June 2, 2026 /PRNewswire/ -- Life science research is entering an AI era, but most discovery teams still cannot use frontier models at scale. Advanced AI models, molecular simulation tools, scientific databases, inference optimization and GPU infrastructure remain fragmented across separa...

2026-06-02 12:00 2659

Chinese Orthopaedic Robot KUNWU® Lands in Brazil, Completing First Clinical Surgery in an International Hospital

HONG KONG, June 2, 2026 /PRNewswire/ -- On 29 May (Brazil local time), an orthopaedic surgical robot from Shenzhen, China, completed its first clinical launch in an international hospital inside an operating theatre at Santa Casa de Jaú Hospital in Jaú, São Paulo. Independently developed by Yuanh...

2026-06-02 11:57 3070

High-Precision Base-Editing Therapy Demonstrates Durable VOC-Free Efficacy and Favorable Safety in Sickle Cell Disease

CorrectSequence Therapeutics Reports Positive 15-Month Follow-Up Data for CS-206 SHANGHAI, June 2, 2026 /PRNewswire/ -- CorrectSequence Therapeutics Co., Ltd. (Correctseq ), a clinical-stage biotechnology company pioneering transformer Base Editi...

2026-06-02 11:38 2467

/C O R R E C T I O N -- Ranok Therapeutics/

In the news release, Ranok Therapeutics Announces Positive Interim Phase 1 Data Of Its KRAS G12D Inhibitor RNK08954 In Patients With KRAS G12D-Mutated Metastatic Non-Small Cell Lung Cancer Presented At ASCO 2026, issued 01-Jun-2026 by Ranok Therapeutics over PR Newswire, we are advised by the co...

2026-06-02 06:16 3611

Phenomenex Launches Endrix Long Life Columns, Redefining Column Durability and Method Reliability

Redefined Column Durability and Method Reliability TORRANCE, Calif., June 1, 2026 /PRNewswire/ -- Phenomenex Inc. , a Danaher Company and a global leader in the research ...

2026-06-01 21:55 2518

Servier to Acquire Edgewise Therapeutics' Muscular Dystrophy Business

* Acquisition supports Servier's strategic ambition in rare neurology for patients with high unmet medical needs. * Transaction includes sevasemten, a late-stage investigational treatment for Becker and Duchenne muscular dystrophies. * Transaction represents total value of up to $2.65 billio...

2026-06-01 20:37 1698

3billion Launches 3B-NEO, a Genomic Newborn Screening Service Covering 595 Clinically Actionable Genetic Conditions

* Screens 595 carefully selected genes associated with childhood-onset conditions where early intervention may improve outcomes * Designed for maternity hospitals, obstetrics practices, newborn care providers, pediatric clinics and families seeking earlier genetic insights from birth * Expa...

2026-06-01 20:20 2070

Waters Unveils Cyclic IMS P20 MS: The New Benchmark in Structural and Spatial Omics

* >10x step-change in MS/MS sensitivity paired with multipass Cyclic™ Ion Mobility Spectrometry (IMS) reveals subtle biological differences for earlier, previously unattainable detection of disease signals. * 50% extended upper mass range and comprehensive suite of structural tools advance th...

2026-06-01 20:00 2200
12345 ... 858

Week's Top Stories